Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2037 of 6351
-
New drug shows promise in reversing lung damage from severe asthma
Disease control OngoingThe purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics. Changes will be assessed over 48 week treatment period in patients with persistent symptoms despite standard therapy of inhaled corticosteroi…
Phase 4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a menopause drug ease schizophrenia symptoms in women?
Symptom relief Recruiting nowTo study the effect of adjunctive bazedoxifene - a selective estrogen receptor modulator (SERM) in a double blind, placebo-controlled adjunctive study in the treatment of women with schizophrenia. All patients receive standardized antipsychotic medication.
Phase 4 • Sponsor: The Alfred • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Baking soda treatment tested for ICU kidney patients
Disease control CompletedSevere metabolic acidemia in the critically ill (pH equal or less than 7.20; PaCO2 equal or less than 45mmHg and bicarbonate concentration equal or less than of 20 mmol/l) is associated with a 50% rate of day 28 mortality. Moderate to severe acute kidney injury is a frequent caus…
Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New study tests safer sedation for tiny lungs
Disease control CompletedThe investigators propose to evaluate premedication with Propofol compared to a control strategy including a placebo with a possible rescue treatment with ketamine to ensure pain control before LISA Procedure . Investigators hypothesize that sedation with Propofol is safe and non…
Phase 3 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New heart valve could spare patients from Open-Heart surgery
Disease control OngoingThe purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of congenital or acquired pulmonary valve stenosis and/or regurgitation who require pulmonary valve replacement.
Sponsor: Taewoong Medical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Deep gene search aims to uncover why some young people get cancer
Knowledge-focused Recruiting now5 to 10% of cancers are due to the presence of a constitutional genetic alteration. It can be inherited from parents (family form) or by accident, in the first moments of life after fertilization (sporadic form). In both cases, this genetic alteration is constitutional and transm…
Sponsor: Centre Georges Francois Leclerc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Steam therapy for enlarged prostate: a new hope?
Disease control Recruiting nowTo document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.
Sponsor: Can-Am HIFU Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for rare kidney patients: Long-Term drug trial shows promise
Disease control Recruiting nowThis is an open-label extension study to evaluate the long-term efficacy, safety and tolerability of iptacopan in subjects with C3 glomerulopathy or idiopathic immune-complex-membranoproliferative glomerulonephritis
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Urine test may spare bladder cancer patients from frequent scopes
Diagnosis OngoingThis observational study evaluates the urine test BladMetrix for monitoring bladder cancer recurrences in people with non muscle invasive bladder cancer (NMIBC) who are in follow-up after surgery. The main goal is to evaluate the potential clinical utility of the BladMetrix test …
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New drug combo shows promise for rare nerve tumors
Disease control CompletedTo determine the clinical benefit rate of selumetinib in combination with sirolimus in patients with unresectable or metastatic neurofibromatosis type 1 (NF1) associated or sporadic MPNST.
Phase 2 • Sponsor: Sarcoma Alliance for Research through Collaboration • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could your voice reveal hidden depression or anxiety?
Knowledge-focused CompletedThis retrospective observational study evaluated the relationship between voice characteristics and self-reported mental health symptoms using longitudinal data collected through the Kintsugi Voice Journaling app. Participants provided voice recordings and completed the Patient H…
Sponsor: Kintsugi Mindful Wellness, Inc. • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Brain zaps show promise for gulf war Vets' pain and mood
Symptom relief CompletedThis study aims to look at the effectiveness of using repetitive transcranial magnetic stimulation (rTMS) in relieving pain and other co-morbid symptoms of Gulf War Illness.
Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can CBD help veterans overcome PTSD? new study puts it to the test.
Symptom relief CompletedThe trial will include a randomized control trial to evaluate the efficacy of using Cannabidiol (CBD), a non-intoxicating cannabinoid, as an adjunctive to Prolonged Exposure therapy (PE). The trial will compare PE + CBD to PE + placebo in a sample of 136 military Veterans with PT…
Phase 2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Can brain training beat Schizophrenia's 'Negative' symptoms?
Symptom relief OngoingThis project will conduct a confirmatory efficacy trial of two novel psychosocial interventions, Cognitive Enhancement Therapy and Enriched Supportive Therapy, for the treatment of persistent negative symptoms in schizophrenia.
Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for Sjögren's syndrome in Mid-Stage trial
Disease control CompletedThis study was to evaluate the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of CFZ533 (iscalimab) in patients with Sjögren's Syndrome (SjS).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a sleep-focused therapy calm bipolar symptoms?
Symptom relief CompletedCognitive Behavioral Therapy (CBT) is treatment of choice for insomnia. Many patients in psychiatric care have sleep problems including insomnia, but are rarely given the choice to participate in CBT to improve their sleep. Patients with Bipolar disorder is a patient group with h…
Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
A simple blood draw may spot kidney cancer early
Diagnosis Recruiting nowThis study aims to observe the difference between NMAP (nicotinamide metabolism associated protein) serum levels in primary diagnosed renal cancer patients and non-renal cancer patient controls, plot the ROC curve and establish appropriate cut-off values.
Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Walking groups could shield HIV-Positive latino men from heart disease
Prevention CompletedThe purpose of this study is to examine the feasibility of an intervention to prevent chronic diseases like diabetes, high blood pressure, and obesity in midlife and older Latino adults living with HIV. The investigators expect that the participant will be in this study for seven…
Sponsor: University of Miami • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Can brain training help TBI patients remember to remember?
Symptom relief OngoingThis research aims to test aspects of a computer-based cognitive rehabilitation program designed to improve thinking skills in individuals with traumatic brain injury (TBI).
Sponsor: Kessler Foundation • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Blood test may predict cancer treatment success
Knowledge-focused OngoingThe PROPHETIC study is a prospective, multi-center, international clinical study aimed at developing an algorithm to predict patient outcomes. The study involves analyzing the proteomic profiles of patients undergoing therapy to assess the likelihood of clinical benefit from thei…
Sponsor: OncoHost Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC